T he baroreceptor reflex, a feedback loop between baroreceptors located in the wall of the carotid sinus, brainstem nuclei, and autonomic fibers projecting to the heart and peripheral vasculature, carefully regulates systemic blood pressure.
vessel wall, minimizing stimulation of carotid baroreceptors, and thereby reducing the incidence and severity of HD. The aim of the present study, therefore, was to examine the hemodynamic changes associated with primary carotid stenting and balloon-assisted stenting. Detailed information on the characteristics and outcomes of the cohort of patients described have been published previously.
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Methods
Patient Population
Between March 2000 and August 2006, 97 patients with 102 symptomatic, severely stenosed carotid arteries were identified, and stents were placed at the London Health Sciences Centre in Ontario, Canada. Data from this cohort were prospectively collected into a registry and analyzed retrospectively. All patients were considered by a neurosurgeon to have relative contraindications for endarterectomy, including prior neck irradiation, prior ipsilateral carotid endarterectomy, age > 80 years, or a concurrent serious illness such as recent myocardial infarction, congestive heart failure, or chronic pulmonary disease.
Stenting Technique
Informed consent was obtained in all patients. The goal at the outset of the procedure was to deploy SES without using angioplasty balloons. An 8-F sheath was inserted in the common femoral artery. Systemic heparinization with an activated clotting time of 2-3 times the baseline level was maintained throughout the procedure.
The common carotid artery was selectively catheterized with a 6-F inner diameter-guiding catheter (Cook Shuttle). Under roadmap guidance, the stenosis was crossed with a 0.014-in guidewire that was advanced to the petrous segment of the internal carotid artery; no embolic protection devices were used. The stenosis was then crossed with an 8-mm-diameter, 40-mm-long SES. Balloon predilation was only performed if required to physically enable the stent to cross the stenosis. A balloon with a diameter of 2-3 mm was generally sufficient for this purpose. The most commonly used stents were: Precise (Cordis; 67 arteries), Smart (Cordis; 12 arteries) and Wallstent (Boston Scientific; 13 arteries). Following stent deployment, angiographic views of the head and neck were obtained. Balloon postdilation was not routinely performed, and there was no minimum lumen diameter required at the end of the procedure. Heparinization was allowed to gradually wear off.
The severity of stenosis was quantified using the North American Symptomatic Carotid Endarterectomy Trial criteria. 22 The degree of lesion calcification was assessed on examination of at least 2 orthogonal views of the neck at the time of angiography or on CT angiograms, if available. The extent of circumferential calcification was quantified on a scale of 0-4: Grade 0 indicated no calcification, Grade 1 indicated flecks of calcification involving < 25%, Grade 2 involving 25-50%, and Grade 3 involving 50-75% of the circumference of the artery. Grade 4 indicated a circumferentially calcified plaque.
Hemodynamic Measurements
Continuous monitoring of blood pressure via a radial artery catheter, and of heart rate and rhythm via electrocardiography was performed during and for 24 hours after the procedure. An automated sphygmomanometer with a cuff on the upper arm was used as a secondary means of measuring blood pressure at 5-minute intervals throughout the procedure and at frequent intervals afterwards. Patients were closely monitored for 24 hours in an observation unit after completion of the stenting procedure.
Periprocedural hypotension was defined as an SBP < 90 mm Hg at any time during or within the first 24 hours after stent deployment. Periprocedural bradycardia was defined as a heart rate < 60 bpm and hypertension as an SBP > 160 mm Hg. These definitions were chosen to facilitate comparison with previous studies that evaluated the hemodynamic changes associated with carotid stenting. 3, 8, 12, 16, 18, 25 
Medications and Fluids
An anesthetist and/or internist assessed all patients prior to the stenting procedure, and medication regimens were optimized. Patients were advised to continue their blood pressure medications until the morning of surgery, and antiplatelet agents were continued up to the time of the intervention. Acetylsalicylic acid and clopidogrel were coadministered for 5 days prior to stenting and 1-month afterward, and then 1 of the agents was discontinued. All stenting procedures were performed without the induction of general anesthesia and with minimal intravenous sedation. An intravenous normal saline infusion was continued throughout the procedure and adjusted to maintain normotension. At the discretion of the anesthetist, vasoactive medications (such as atropine, glycopyrrolate, ephedrine, or phenylephrine) were administered intravenously to treat severe hypotension and/or bradycardia that did not rapidly respond to intravenous fluids. Similarly, hypertension was treated with either labetolol or hydralazine. Atropine or glycopyrrolate were not prophylactically administered before stenting in any patient.
Statistical Analysis
Descriptive statistics were calculated for all patients and between patient groups separately. To avoid clustering effects, only the first artery treated was included for further analysis in patients in whom both carotid arteries were stented (5 patients). Logistic regression techniques were used to calculate ORs, 95% CIs, and to perform statistical comparisons of the groups. Only variables with a probability value < 0.05 were allowed to enter the multivariable regression model; probability values < 0.05 were considered statistically significant.
Results
Deployment of an SES alone was successful in 77 patients (79%) and concurrent angioplasty was required in 20 (21%). The average patient age was 72 years (range 50-91) and 71% (69 of 97) were men. All patients had at least 1 vascular risk factor, including diabetes mellitus (28%), hypertension (90%), hyperlipidemia (81%), coronary artery disease (65%), and were currently smokers or had a history of smoking (79%). Ten patients (10%) had previously undergone ipsilateral carotid endarterectomy, and 4 (4%) had had prior neck irradiation. Eighty-eight patients (90%) had severe (> 70%) carotid stenoses at the time of angiography. Only 8 patients had moderate (50-69%) stenosis. The contralateral ICA was severely stenosed in 15 patients (15%) and occluded in 14 (14%).
Balloon predilation was required in 13 patients to enable the stent to cross the stenosis. In no case was postdilation performed because of persistent residual stenosis after stent placement; however, it was required to dilate and position the overlapping stents necessary to cover the stenosis in 2 patients, because of: 1) acute thrombus formation and/or plaque extrusion at the time of stent deployment, which caused severe stenosis or occlusion in 3 patients; and 2) severe restenosis noted on early follow-up in 2 patients (after 1 and 3 months of follow-up). Angioplasty performed before and after stent placement was required in 1 patient. The average extent of stenosis in patients treated with stent placement alone immediately decreased from 82% (range 58-95%) to 40% (range 0-73%).
In patients who required angioplasty, the average extent of stenosis decreased from 89% (range 73-99%) to 37% (range 7-64%).
In the periprocedural period (30 days), the combined rate of stroke or death in all patients was 7.2%, with 5 ipsilateral ischemic strokes and 2 deaths. There were no intracerebral hemorrhages or myocardial infarctions. Other complications included vessel injury (2 patients), retroperitoneal hematoma (1 patient), and sublingual hematoma (1 patient). Six months of follow-up data is available in 70 patients, and 1 year in 44 patients. Excluding the periprocedural period, the ipsilateral stroke rate was 0 after 6 months, and 2% (1/44) after 1 year.
Intraprocedural HD
Intraprocedural bradycardia (heart rate < 60 bpm) was present in 29 patients (38%) who underwent stent treatment alone, and in 14 patients (70%) who received SES and angioplasty (p = 0.012; Table 1 and Fig. 1 ). Hypotension (SBP < 90 mm Hg) occurred in 1 patient (1%) who received stent treatment alone, and in 4 patients with SES and angioplasty (20%; p = 0.001). Asystole did not develop in any patient during the procedure. In the stent-only group, 9% (7 patients) required atropine, glycopyrrolate, or vasopressor treatment, compared to 35% (7 patients) of those in whom balloons were used (p = 0.009). Periprocedural stroke (< 30 days postoperatively) developed in 1 patient with hemodynamic instability who underwent angioplasty and stent placement.
Several factors were identified on univariate logistic regression analysis as associated with an increased risk of intraprocedural bradycardia or hypotension (Table 2) : baseline SBP (p = 0.033), baseline DBP (p = 0.020), baseline heart rate (p < 0.001), ipsilateral endarterectomy (p = 0.043), plaque ulceration (p = 0.018), and balloon angioplasty (p = 0.016). Other factors such as age, sex, diabetes, smoking status, coronary artery disease, and lesion calcification showed no significant association. On multivariate regression analysis, only the baseline heart rate (OR = 0.887, 95% CI 0.839-0.938; p < 0.001) and treatment with angioplasty (OR = 4.428, 95% CI 1.08-18.159; p = 0.039) were independently associated with an increased risk of intraprocedural bradycardia or hypotension.
Postprocedural HD
Postprocedural bradycardia developed in 21 patients (27%) who received stents alone and in 12 (60%) who also had balloon angioplasty (p = 0.008). Hypotension occurred after the procedure in 7 patients (9%) with stenting alone and 4 patients (20%) with balloon angioplasty (p = 0.185) after the procedure (Table 1 and Fig. 2) . Most of these patients were either asymptomatic or responded well to conservative treatment with intravenous fluids. No patient required atropine or glycopyrrolate administration. In 2 patients with postprocedural hypotension, 1 who received SES alone and the other who underwent SES with balloon angioplasty, retroperitoneal hematomas were diagnosed, requiring fluids, vasopressors, and blood transfusion. One of these patients died of multisystem complications 3 months later.
Factors associated with postprocedural hypotension or bradycardia on univariate logistic regression analysis (Table 4) .
Intra-and Postprocedural Hypertension
We reasoned that the factors associated with intra-or postprocedural hypertension (SBP > 160 mm Hg) would be different from those that increased the risk of hypotension and bradycardia. Of patients treated with SES alone, 45 (58%) had elevated SBP during the procedure, and 38 (38%) afterward. Similar proportions of patients who required angioplasty had hypertension during (10 patients [50%]; p = 0.421) and after the procedure (5 patients [25%]; p = 0.257). No patient with intra-or postprocedural hypertension developed hyperperfusion syndrome or intracranial hemorrhage. One factor associated with intra-(OR = 1.044, 95% CI 1.021-1.067; p ≤ 0.001) and postprocedural hypertension (OR = 1.041, 95% CI 1.019-1.063; p ≤ 0.001) on univariate and multivariate logistic regression analysis was the baseline SBP. The presence of severe, concentric plaque calcification (Grades 3 and 4) was also independently associated with elevated blood pressure during the stenting procedure (OR = 3.058, 95% CI 1.158-8.077; p = 0.024) and intraprocedural hypertension (OR = 6.755, 95% CI 1.946-23.433; p = 0.003) was independently associated with postprocedural hypertension on multivariate regression analysis (Table 4) .
Discussion
Hemodynamic instability is frequently seen in CAS, primarily at the time of balloon inflation. 3, 6, 8, 12, 16, 18, 25 Fortunately, intraprocedural bradycardia and/or hypotension can usually be managed conservatively or with intravenous fluids and medications, such as atropine or glycopyrrolate, and confers no increased periprocedural risk.
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Gupta et al. 8 reported persistent hemodynamic depression requiring vasopressor support develops in up to 17% of patients. This phenomenon was associated with an increased risk of developing major periprocedural adverse clinical events or stroke. Patients with HD in this cohort also had longer periods of hospitalization compared with patients without HD. Similar observations have been made in other cohorts.
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In most North American centers, endovascular treatment of carotid stenosis involves placement of an embolic protection device, followed by deployment of a stent across the stenosis, and then balloon dilation. Predilation may be required to physically enable the protection device or stent to cross the stenosis, and postdilation may be required to achieve a minimal luminal diameter. In the Carotid Revascularization Endarterectomy Versus Stenting Trial, 9 for example, a final stenosis of < 30% was required at the end of the procedure. Self-expanding stents alone without angioplasty were used in 79% of patients in our cohort, providing a unique opportunity to examine the hemodynamic effects of SES placement alone or with concurrent angioplasty. Hemodynamic depression was significantly more frequent in patients who required angioplasty. Intraprocedural hypotension was 20 times more frequent (p = 0.001) and bradycardia was twice as frequent (p = 0.012) in patients treated with balloons compared to those with SES alone. During the first 24 hours after the procedure, there was no significant difference in the incidence of hypotension between the groups, although bradycardia was again seen twice as frequently in patients with angioplasty (p = 0.008). The sustained outward force of an SES appears to be a weak stimulus to the stretch receptors in the region of the carotid sinus, whereas forceful dilation with a balloon is a strong stimulus.
Baseline heart rate was also found to be independently associated with HD. Not surprisingly, patients with lower heart rates prior to the procedure were more likely to develop bradycardia or hypotension during or after the procedure. Other studies have suggested several additional factors that predispose patients to hemodynamic instability during carotid angioplasty and stenting, including age, 18 rotid stenosis 12 and SBP elevated above 180 mm Hg prior to the procedure. 10 Most of these factors were not found to be significant predictors in our analysis. Calcification and elevated baseline blood pressure were associated with periprocedural hypertension.
Persistent HD 8 developed in 2 patients in our cohort. Intraoperatively, there were no heart rate or blood pressure changes in either patient, but hypotension developed within a few hours of completing the procedure in both patients, requiring intravenous fluid infusions and vasopressor support. Retroperitoneal hematomas were found in both of these patients, and 1 died of multisystemic complications 3 months later. Thus, persistent HD also appears to correlate with adverse periprocedural events in our cohort.
We did not observe any instances of hyperperfusion syndrome among our patients. This syndrome is an uncommon but serious complication of endarterectomy or CAS that consists of headache, seizures, confusion, and focal signs often associated with intracerebral hemorrhage that arise within hours to days after treatment. 1, 5, 7, 11, 17, 19 This condition is thought to occur secondary to a sudden elevation of cerebral blood flow in a maximally dilated vascular bed in which cerebral autoregulation is impaired. The precise pathophysiological mechanisms have yet to be elucidated, and the incidence after carotid angioplasty and stenting ranges from 1.1-6.8%. 1, 5, 7, 11, 17, 19 Factors associated with an increased risk of hyperperfusion syndrome include advanced age, severe bilateral stenosis, periprocedural hypertension, poor collateral vessels, and prior minor stroke. 1, 5, 7, 11, 17, 19 It is possible that we did not observe hyperperfusion syndrome in our patients because of its infrequent occurrence and the relatively small size of our cohort. Alternatively, the risk of this syndrome might be increased when balloons are used compared to SES placement alone. This hypothesis, however, can only be confirmed or refuted in a large randomized study comparing these approaches directly. There are several limitations to the present study. First, all patients in this cohort were recently symptomatic, and thus, it remains uncertain whether the observations made in this article and its companion article, 2 apply to patients with asymptomatic carotid disease. Second, our data were obtained in a nonrandomized sample of patients, and thus, differences in baseline patient or angiographic characteristics not included in the analysis might have accounted for some of the differences observed between groups. In particular, the registry analyzed did not include information on patient medications. An imbalance in certain vasoactive medications, such as beta blockers or calcium channel blockers, might explain the more frequent occurrence of HD in patients who underwent angioplasty. In other studies, however, these medications have not been shown to alter the development of HD significantly. 3, 25, 27 Gupta et al. 8 found a nonsignificant trend toward a protective effect of beta blockers on the development of persistent HD.
Third, we have previously reported that patients who require angioplasty after unsuccessful primary stenting tended to have more severe stenoses, circumferential plaque calcification, and no history of hyperlipidemia.
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These factors could be postulated to account for the higher rates of hemodynamic instability in the angioplasty group and were included as variables in the logistic regression analysis in an attempt to account for them as potential confounders. Only the use of balloons and the baseline heart rate were found to be independently associated with intra-or postprocedural hypotension or bradycardia by multivariate analysis.
Fourth, the precise extent and location of the atherosclerotic lesion at the internal carotid artery origin was not documented in this registry. As we have already mentioned, patients with atherosclerotic lesions involving the carotid bulb may be at an increased risk of HD.
8,21
Atherosclerotic plaque involves the bulb in the majority of patients, however, and the proximal portion of the deployed stent invariably extends across the bulb into the distal common carotid artery. Such factors are unlikely to account for the large differences in frequency of HD seen between patients who receive SES alone and those with angioplasty.
Lastly, specific aspects of the angioplasty technique (such as balloon diameter, inflation rate, and nominal inflation pressure) could play a role in the hemodynamic changes that occur during carotid angioplasty, but these factors were not specifically recorded or included in our analysis. Given that only 20 patients in this cohort required balloon angioplasty, it would not have been statistically feasible or meaningful to analyze these additional subfactors. A larger cohort of patients is required for such an analysis.
Conclusions
Hemodynamic instability during and after carotid artery stenting was observed more frequently when balloon angioplasty was used than when stent placement was performed without concurrent balloon angioplasty. 
